Northrop Grumman Reaffirms Sales, Lifts Capex for B-21

Northrop Grumman has reaffirmed its 2026 sales outlook of $43.5 billion-$44 billion and increased its 2026 capital expenditure to $1.85 billion to support the ramp-up of the B-21 bomber program.